Not Medicare Enrolled

Dr. William Sheldon, M.D.

Endocrinology · Plano, TX
Low-engagement
5930 W PARKER RD STE 700, Plano, TX 75093
9729437626
In practice since 2006 (19 years)
NPI: 1386651180 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sheldon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sheldon? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sheldon

Dr. William Sheldon is an endocrinology in Plano, TX, with 19 years in practice.

Between the years covered by Open Payments, Dr. Sheldon received a total of $7,926 from 36 pharmaceutical and/or device companies across 287 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sheldon is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $7,926 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$7,926
Total received (2018-2024)
Avg $1,585/year across 5 years
Top 37% in TX for endocrinology
36
Companies
287
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,923 (87.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,003 (12.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$125
2021
$568
2020
$1,505
2019
$3,491
2018
$2,237

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,985
SANOFI-AVENTIS U.S. LLC
$1,648
Novo Nordisk Inc
$716
Lilly USA, LLC
$439
Amarin Pharma Inc.
$390
Mannkind Corporation
$326
Amgen Inc.
$316
Boehringer Ingelheim Pharmaceuticals, Inc.
$240
AbbVie Inc.
$211
Dexcom, Inc.
$170
Radius Health, Inc.
$169
IBSA Pharma Inc.
$150
Kowa Pharmaceuticals America, Inc.
$123
Insulet Corporation
$121
AbbVie, Inc.
$118
Merck Sharp & Dohme Corporation
$112
Valeritas, Inc.
$84
PFIZER INC.
$65
Esperion Therapeutics, Inc.
$53
Shire North American Group Inc
$48
Zealand Pharma US, Inc.
$46
Corcept Therapeutics
$43
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$42
Amneal Pharmaceuticals LLC
$41
Becton, Dickinson and Company
$35
KVK-Tech, Inc.
$34
Antares Pharma, Inc.
$31
Janssen Pharmaceuticals, Inc
$28
Medtronic MiniMed, Inc.
$28
Tandem Diabetes Care, Inc.
$21
ARBOR PHARMACEUTICALS, INC.
$17
Takeda Pharmaceuticals U.S.A., Inc.
$17
GRT US Holding, Inc.
$17
Arbor Pharmaceuticals, Inc.
$16
Ultragenyx Pharmaceutical Inc.
$13
MannKind Corporation
$12
Top 3 companies account for 54.9% of total payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · BD Nano · CYCLOSET · Crysvita · DEXCOM G6 CGM SYSTEM · Dexcom CGM · EVENITY · Edarbi · FARXIGA · FORTEO · HUMULIN U · INVOKANA · JANUVIA · JARDIANCE · Korlym · LYUMJEV · Livalo · Minimed 670G System · NATPARA · NEXLETOL · NO PRODUCT DISCUSSED · OTREXUP · Omnipod · Ozempic · Qutenza · Repatha · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SOTAGLIFLOZIN · STEGLATRO · SYNTHROID · Saxenda · Synthroid · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tresiba · Trintellix · Tymlos · UNITHROID · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Victoza · XYOSTED · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a endocrinology in Plano?
Compare endocrinologys in the Plano area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
97
Per 100K population
8.7
County median income
$117,588
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sheldon is a endocrinology, and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Sheldon receive payments from pharmaceutical companies?
Yes. Dr. Sheldon received a total of $7,926 from 36 companies across 287 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Sheldon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologys in Plano
Browse endocrinologys in Plano ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologys in TX
Endocrinologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologys in TX
Which TX endocrinologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →